View of Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis

Return to Article Details Recent targeted therapies addition to standard chemotherapy regimen in mismatch repair deficient (Dmmr) primary advanced or recurrent endometrial cancer, to what significance? A network meta-analysis Download Download PDF

Cited by

	All	Since 2021
Citations	4172	3945
h-index	25	25
i10-index	92	92

0

2200

1100

550

1650

20152016201720182019202020212022202320242025202619 18 22 30 44 60 102 297 354 581 2107 462